1. Home
  2. AVNW vs BMEA Comparison

AVNW vs BMEA Comparison

Compare AVNW & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNW
  • BMEA
  • Stock Information
  • Founded
  • AVNW 2006
  • BMEA 2017
  • Country
  • AVNW United States
  • BMEA United States
  • Employees
  • AVNW N/A
  • BMEA N/A
  • Industry
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • BMEA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVNW Technology
  • BMEA Health Care
  • Exchange
  • AVNW Nasdaq
  • BMEA Nasdaq
  • Market Cap
  • AVNW 283.7M
  • BMEA 275.6M
  • IPO Year
  • AVNW 2007
  • BMEA 2021
  • Fundamental
  • Price
  • AVNW $14.39
  • BMEA $8.18
  • Analyst Decision
  • AVNW Strong Buy
  • BMEA Buy
  • Analyst Count
  • AVNW 5
  • BMEA 13
  • Target Price
  • AVNW $38.60
  • BMEA $37.25
  • AVG Volume (30 Days)
  • AVNW 238.5K
  • BMEA 805.0K
  • Earning Date
  • AVNW 11-05-2024
  • BMEA 10-29-2024
  • Dividend Yield
  • AVNW N/A
  • BMEA N/A
  • EPS Growth
  • AVNW N/A
  • BMEA N/A
  • EPS
  • AVNW N/A
  • BMEA N/A
  • Revenue
  • AVNW $409,603,000.00
  • BMEA N/A
  • Revenue This Year
  • AVNW $14.67
  • BMEA N/A
  • Revenue Next Year
  • AVNW $17.60
  • BMEA N/A
  • P/E Ratio
  • AVNW N/A
  • BMEA N/A
  • Revenue Growth
  • AVNW 17.00
  • BMEA N/A
  • 52 Week Low
  • AVNW $12.96
  • BMEA $3.61
  • 52 Week High
  • AVNW $38.85
  • BMEA $22.74
  • Technical
  • Relative Strength Index (RSI)
  • AVNW 23.70
  • BMEA 32.99
  • Support Level
  • AVNW $12.96
  • BMEA $8.60
  • Resistance Level
  • AVNW $20.95
  • BMEA $9.34
  • Average True Range (ATR)
  • AVNW 0.97
  • BMEA 0.81
  • MACD
  • AVNW -0.74
  • BMEA -0.45
  • Stochastic Oscillator
  • AVNW 14.26
  • BMEA 3.11

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures, and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Share on Social Networks: